Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tor Hervig

Showing results (21-30 of 118) with videos related to

Pageof 12
Sort By:
Expert Opinion on Investigational Drugs|August 17, 2022
Pure red cell aplasia after hematopoietic stem cell transplantation - experimental therapeutic approachesAnh Khoi Vo, Tor Hervig, Håkon Reikvam
Clinical Biochemistry|June 20, 2006
A novel HPLC method for the measurement of thiobarbituric acid reactive substances (TBARS). A comparison with a commercially available kitEsben Seljeskog, Tor Hervig, Mohammad Azam Mansoor
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 26, 2003
[Thrombocytopaenia in pregnancy]Kjell Haram, Eirik Søfteland, Tor Hervig, et al.
Journal of Biomedicine & Biotechnology|July 14, 2010
Combination of intensive chemotherapy and anticancer vaccines in the treatment of human malignancies: the hematological experienceKnut Liseth, Elisabeth Ersvaer, Tor Hervig, et al.
International Journal of Cancer|January 5, 2002
Effects of cytarabine and various anthracyclins on platelet activation: characterization of in vitro effects and their possible clinical relevance in acute myelogenous leukemiaBrynjar Foss, Elling Ulvestad, Tor Hervig, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|November 24, 2004
Guidelines for transfusion in NorwayTor Hervig, Oystein Flesland, Vibeke Svenningsen, et al.
International Journal of Molecular Sciences|July 24, 2021
Platelet Microparticles Decrease Daunorubicin-Induced DNA Damage and Modulate Intrinsic Apoptosis in THP-1 CellsDaniel Cacic, Oddmund Nordgård, Peter Meyer, et al.
Cytotherapy|March 5, 2024
The expanding role of blood and tissue establishments in the development of advanced therapy medicinal productsAisling Horan, Shada Warreth, Tor Hervig, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|June 15, 2017
Hemochromatosis and blood donationTurid Aarhus Braseth, Tor Hervig, Anne Synnove Rosvik
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 20, 2004
[Blood transfusion and pretransfusion testing in patients with warm autoimmune haemolytic anaemia]Guro Kristin Melve, Tor Hervig, Ragnhild Øvrebøe, et al.
Pageof 12

Showing results (21-30 of 118) with videos related to

Sort By:
Pageof 12
Expert Opinion on Investigational Drugs|August 17, 2022
Pure red cell aplasia after hematopoietic stem cell transplantation - experimental therapeutic approachesAnh Khoi Vo, Tor Hervig, Håkon Reikvam
Clinical Biochemistry|June 20, 2006
A novel HPLC method for the measurement of thiobarbituric acid reactive substances (TBARS). A comparison with a commercially available kitEsben Seljeskog, Tor Hervig, Mohammad Azam Mansoor
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 26, 2003
[Thrombocytopaenia in pregnancy]Kjell Haram, Eirik Søfteland, Tor Hervig, et al.
Journal of Biomedicine & Biotechnology|July 14, 2010
Combination of intensive chemotherapy and anticancer vaccines in the treatment of human malignancies: the hematological experienceKnut Liseth, Elisabeth Ersvaer, Tor Hervig, et al.
International Journal of Cancer|January 5, 2002
Effects of cytarabine and various anthracyclins on platelet activation: characterization of in vitro effects and their possible clinical relevance in acute myelogenous leukemiaBrynjar Foss, Elling Ulvestad, Tor Hervig, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|November 24, 2004
Guidelines for transfusion in NorwayTor Hervig, Oystein Flesland, Vibeke Svenningsen, et al.
International Journal of Molecular Sciences|July 24, 2021
Platelet Microparticles Decrease Daunorubicin-Induced DNA Damage and Modulate Intrinsic Apoptosis in THP-1 CellsDaniel Cacic, Oddmund Nordgård, Peter Meyer, et al.
Cytotherapy|March 5, 2024
The expanding role of blood and tissue establishments in the development of advanced therapy medicinal productsAisling Horan, Shada Warreth, Tor Hervig, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|June 15, 2017
Hemochromatosis and blood donationTurid Aarhus Braseth, Tor Hervig, Anne Synnove Rosvik
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 20, 2004
[Blood transfusion and pretransfusion testing in patients with warm autoimmune haemolytic anaemia]Guro Kristin Melve, Tor Hervig, Ragnhild Øvrebøe, et al.
Pageof 12